News and Announcements
Shivom Successfully Raised $33 Million in the Private and Pre-sale Round and is Now Only $2 Million Away From Reaching Hardcap
- Published April 29, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom’s Presale has now closed
- Closed the sale with 33 $ million dollars
- Main crowdsale that begins on May 3rd
Shivom’s Presale has now closed and we cannot thank you enough for making it an overwhelming success! We closed the sale with 33 $ million dollars and are now all geared up for the main crowdsale that begins on May 3rd, 2018 (next week!) We are now one step closer to achieving our targets and we couldn’t have reached this far without your continued support.
The success of our presale is a great encouragement for us to keep striving to reach our goals of building the world’s best platform to improve the global healthcare system. With your continued supportwe are well on our way to begin developing our platform for safe and secure DNA sequencing and data storage and sharing for advancement of precision medicine.
Shivom’s Journey
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
Backed By Leading Investment Groups and Family Offices
